WO1998038904A1 - Biological measurement system - Google Patents

Biological measurement system Download PDF

Info

Publication number
WO1998038904A1
WO1998038904A1 PCT/GB1998/000702 GB9800702W WO9838904A1 WO 1998038904 A1 WO1998038904 A1 WO 1998038904A1 GB 9800702 W GB9800702 W GB 9800702W WO 9838904 A1 WO9838904 A1 WO 9838904A1
Authority
WO
WIPO (PCT)
Prior art keywords
acoustic
body part
light
energy
photoacoustic
Prior art date
Application number
PCT/GB1998/000702
Other languages
French (fr)
Inventor
Hugh Alexander Mackenzie
John Matthew Lindberg
Original Assignee
Optel Instruments Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optel Instruments Limited filed Critical Optel Instruments Limited
Priority to CA002282855A priority Critical patent/CA2282855A1/en
Priority to JP53829398A priority patent/JP2001526557A/en
Priority to EP98909587A priority patent/EP0967913A1/en
Priority to US09/380,640 priority patent/US6403944B1/en
Priority to AU64079/98A priority patent/AU6407998A/en
Publication of WO1998038904A1 publication Critical patent/WO1998038904A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/1702Systems in which incident light is modified in accordance with the properties of the material investigated with opto-acoustic detection, e.g. for gases or analysing solids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0093Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
    • A61B5/0095Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying light and detecting acoustic waves, i.e. photoacoustic measurements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6814Head
    • A61B5/6815Ear
    • A61B5/6816Ear lobe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6825Hand
    • A61B5/6826Finger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683Means for maintaining contact with the body
    • A61B5/6838Clamps or clips
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/1702Systems in which incident light is modified in accordance with the properties of the material investigated with opto-acoustic detection, e.g. for gases or analysing solids
    • G01N2021/1708Systems in which incident light is modified in accordance with the properties of the material investigated with opto-acoustic detection, e.g. for gases or analysing solids with piezotransducers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/061Sources
    • G01N2201/06113Coherent sources; lasers
    • G01N2201/0612Laser diodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/08Optical fibres; light guides

Definitions

  • This invention relates to apparatus for use in non- invasive in vivo monitoring of physiological substances such as blood and the like.
  • One particular, but not exclusive, application of the present invention is in the monitoring of blood glucose, for example in the management of diabetes mellitus. It is accepted that the management of diabetes can be much improved by routine monitoring of blood glucose concentration and clinicians suggest that monitoring as often as four times per day is desirable.
  • the monitoring technique currently available for use by patients involves using a spring loaded lancet to stab the finger to obtain a blood sample which is transferred to a glucose test strip.
  • the concentration is derived either by reading the test strip with a reflectance meter or by visual comparison of colour change against a colour scale.
  • Many diabetics find the testing onerous as the technique is painful, inconvenient, messy, potentially embarrassing and offers a site for the transmittance and acceptance of infection.
  • Techniques have also been developed for non invasive measurement using transmittance or reflectance spectroscopy . However the required instruments are expensive and it is difficult to obtain accurate and repeatable measurements .
  • the present invention makes use of photoacoustic techniques.
  • the fundamentals of photoacoustic techniques are well known per se.
  • a pulse of light typically laser light, is applied to a substance containing an analyte of interest in solution or dispersion, the wavelength of the applied light being chosen to interact with the analyte.
  • Absorption of the light energy by the analyte gives rise to microscopic localised heating which generates an acoustic wave which can be detected by an acoustic sensor.
  • the present invention provides a sensor head for use in photoacoustic in vivo measurement, comprising a housing shaped to engage a selected body part, light transmission means terminating in said housing so as to transmit light energy from a light source to enter the body part along a beam axis, and acoustic transducer means mounted in the housing to receive acoustic waves generated by photoacoustic interaction within the body part, the acoustic transducer means being disposed in the housing to receive said acoustic wave in a direction of high acoustic energy.
  • the transducer means is disposed so as to intercept acoustic energy propagating at right angles to the optical beam axis, or at an angle to the optical beam axis which may be down to about 20°, typically about 45°.
  • the signal measured at the detector is just the superposition of all pressure waves from all points that are illuminated by the source light.
  • An analytical solution for the pressure wave has been worked out for a few cases in aqueous material.
  • the analytical case that best matches the in-vivo measurements is that of a cylindrical optical beam propagating in a weekly absorbing material.
  • the direction of highest acoustic energy is perpendicular to the optical axis.
  • the base detector location is with the plane of the detector perpendicular to the acoustic energy, or parallel to the optical axis. This is because the acoustic detector has the highest sensitivity when the acoustic energy strikes the detector perpendicular to the plane of the detector.
  • the acoustic transducer means is arranged parallel to the optical beam axis. This arrangement is particularly suitable for use where the selected body part is the distal portion of a finger, in which case the housing may include a generally half-cylindrical depression in which the finger may be placed with the light transmission means aimed at the end of the finger.
  • the acoustic transducer means comprises a piezoelectric transducer which most preferably is of a semi-cylindrical shape.
  • This transducer may be provided with a backing of lead or other dense material, and the backing may have a rear surface shaped to minimise internal acoustic reflection.
  • Alternative transducer means include a capacitor-type detector, which is preferably small and disk-shaped; an integrated semiconductor pressure sensor; and an optical pressure sensor, for example based on an optical fibre.
  • the plane of the transducer may be arranged to be perpendicular to the optical axis to detect the acoustic wave which is propagating in a direction opposite to the direction of the light beam.
  • the acoustic transducer means may be part-spherical with an aperture to allow access for the light beam. This may be particularly suitable for engagement with a body part other than the finger, for example the back of the arm.
  • a surface wave detector may be provided in the sensing head assembly.
  • Preferably means are provided for ensuring a consistent contact pressure between the selected body part and the acoustic transducer means.
  • said means may be provided by mounting the portion of the housing engaged by the finger in a resiliently biased fashion against the remainder of the housing, and providing means to ensure that measurement is effected when the predetermined force or pressure is applied by the subject against the resilient bias.
  • said means may be provided by placing the ear between two plates and applying pressure to the ear with springs or weights or other force method.
  • the two plates holding the ear may contain a removable insert.
  • the two plates may be flat or may be of another shape to optimally position the detector with respect to the beam axis.
  • the present invention provides a sensor head for use in photoacoustic in-vivo measurements, comprising a housing shaped to receive a removable insert, a removable insert that engages a selected body part, the insert being fitted to an individual, allowing for a range of sizes of body parts to be used, and further comprising light transmission means terminating in or near said removable insert so as ⁇ to transmit light energy from a light source or sources to enter the body part along a beam axis, and an acoustic transducer means mounted in the housing or in the removable insert to receive acoustic waves generated by photoacoustic interaction within the body part to receive said acoustic waves in a direction of high acoustic energy.
  • the present invention provides an in vivo measuring system comprising a sensor head as hereinbefore defined in combination with a light source coupled with the light transmission means, and signal processing means connected to receive the output of the acoustic transducer means and to derive therefrom a measurement of a selected physiological parameter.
  • the light transmission means is a fiber distribution system where each light source is connected to an individual fiber and when multiple light sources are used the multiple fibres are joined by some standard fiber combining method, such as a wavelength division multiplexer or a fiber coupler.
  • the fiber that comes from the light source, or contains the combined light for a multiple source system, is then terminated in proximity to the body part being measured.
  • the fiber could be in contact with the body part or alternatively standard optics, such as lenses, beamsplitters and such, could be employed to convey the light from the end of the fiber to the body part.
  • a reference detector or several reference detectors and beamsplitters can be added to the optical distribution system to determine the energy of the light entering the body part.
  • the optical distribution system may contain mechanical holders, lenses and such to convey the light from the source, or sources, to a location in proximity to the body part being measured.
  • a reference detector or several reference detectors and beamsplitters can be added to the optical distribution system to determine the energy of the light entering the body part.
  • the acoustic signal from the detector contains information in both time and frequency, and there may be information from several sources.
  • the processing means is preferably a multi-dimensional processing method, such as Classical Least Squares (CLS) or Partial Least Squares (PLS).
  • CLS Classical Least Squares
  • PLS Partial Least Squares
  • the processing method may be more flexible, such as a Neural Network.
  • the signals may be analysed for their frequency content using such techniques as Fourier Analysis or Frequency Filtering
  • time information such as the time delay from source trigger. Techniques that combine both frequency and time information may be employed, such as Wavelet analysis.
  • the light source is preferably a laser light source and is most suitably a pulsed diode laser, but may utilise a set of such lasers or utilise a tunable laser source.
  • a laser diode is used with a wave length in the range of approximately 600 nm to 10,000 nm and a pulse duration of the order of 5 to 500 ns.
  • the delivery to the measurement site may be either directly or by optical fibre with a suitable optical element to focus the beam into the tissue.
  • Each source is switched on, and it generates an optical pulse, or a set of optical pulses. This pulse, or set of pulses, generates an acoustic signal that is detected by the detector.
  • Each source is pulsed in sequence until all sources have been used to generate their own signal.
  • the measuring system may conveniently be in the form of a self contained system including a power supply and a readout, which may be carried on the person and used at any convenient time.
  • Such a self contained system may incorporate, or to be provided with facilities for connection to, a cellular telephone, two-way pager or other communication device for routine transmission of measurements taken to a central data collection point.
  • the measuring system may have provision for manipulating the body part under measurement and for performing additional measurement of the tissue to get other information about the state of the physiology of the issue. It is well-known in the art that squeezing a section of tissue to increase the pressure and then releasing the pressure will cause changes in the total blood volume in the measurement site.
  • the present invention may allow for this type of manipulation including the squeezing of a body part, such as an earlobe, and making photo acoustic measurements at several different pressures.
  • the present invention may also allow for the measurement of the temperature of the body site and to apply a correction to the measurements based upon the temperature of the body site.
  • body temperature Another type of physiological manipulation is body temperature. It is known in the art that several parameters involved in the detection of the photo acoustic signal, such as the speed of sound, are dependent upon the temperature of the medium the signal is propagating through (the tissue). Also the profusion of the blood in the small capillaries is dependent upon the temperature of the tissue. Additional information about the tissue can be obtained if the photo acoustic measurement is made at several temperatures, both higher and lower than ambient temperature. This additional information is used to better eliminate interferences to the determination of the analyte under investigation. These are only two examples of manipulating the body site and are not intended to be an exhaustive list, and they can be used in combination with other manipulation techniques.
  • the in-vivo measuring system may comprise a means for storing calibration coefficients or operation parameters or both calibration coefficients and operational parameters, in order to calibrate the instrument and to set critical operational parameters.
  • Another aspect of the present invention provides a means for adjusting the calibration coefficients and operational parameters to be specific to a particular person and may be used to adjust for such things as body part size, skin color, skin condition, amount of body fat, efficiency of the detector and efficiency of the source ( s ) .
  • the present invention may provide for having the specific calibration coefficients and operational parameters be contained in a storage site located in the removable insert. This allows for the system to be both mechanically and operationally configured to a particular individual. Additionally the invention may allow for the calibration coefficients and operational parameters to be stored in two locations, one in the non-removable housing and one in the removable insert with some of the coefficients and parameters stored in each location. This allows for reader system coefficients to be stored in the reader and coefficients specific to an individual to be stored in the removable insert for that person, enabling many people to use the same reader.
  • Another aspect of the present invention provides means for connecting the non-invasive measuring system to an invasive measuring system for the purpose of calibrating or adjusting the operational parameters of the non-invasive measuring system.
  • Such connection may be accomplished, but is not limited to, communication by a wire, IR link or radio waves.
  • Another aspect of the present invention provides a method for removing instrument drift from the measurement comprising the steps of:
  • a correction factor can be calculated for the instrument temperature. This can be applied to each signal with a different correction coefficient.
  • the invention further provides a method of measuring a biological parameter in a subject, the method comprising the steps of:
  • Figs. 1A,1B and IC are side views illustrating the principle of operation of one embodiment of the present invention.
  • Fig. 2 is a schematic perspective view showing a sensor head for use in carrying out the measurement illustrated in Fig. 1;
  • Fig 3. is a cross section view of the sensor head of Fig. 2;
  • Fig. 4 is a side view of the sensor head of Fig. 2;
  • Fig. 5 is a schematic perspective view of an apparatus incorporating the sensor head of Figs. 2 to 4;
  • Fig. 6 is a perspective view illustrating an alternative form of sensor head;
  • Fig. 7 is a schematic end view showing another form of sensor head
  • Figs. 8a and 8b are a cross-sectional side view and a plan view, respectively, of a further sensor head
  • Fig. 9 is a cross-sectional side view of one more embodiment of sensor head.
  • Fig. 10 is a perspective view of one type of ear interface apparatus
  • Fig. 11 is a schematic of a multiple laser optical distribution system using lenses, mechanical mounts and a reference detector
  • Fig. 12 is a schematic of a multiple laser optical distribution system using fiber optic cables and a fiber Wavelength Division Multiplexer (WDM), a beam splitter and a reference detector;
  • WDM Wavelength Division Multiplexer
  • Fig. 13 is a perspective view of a finger interface apparatus with removable inserts that are moulded to fit one individual;
  • Fig. 13A shows part of the apparatus of Fig. 13 in greater detail
  • Fig. 14 is a schematic of a semi-spherical detector that contains a hole for the light beam, with a vacuum system and a fiber distribution system;
  • Fig. 15 is a perspective view showing one form of the instrument utilizing the vacuum body interface, a semi-spherical detector and the multiple laser source with lenses and mechanical housing;
  • Fig. 16 is a perspective view showing one form of the instrument using an ear lobe body interface, with the added feature of being able to manipulate the pressure on the ear lobe;
  • Figs. 17, 18 and 19 are graphs illustrating an example.
  • an important feature of the present invention lies in introducing light energy along an axis into an area of soft tissue and detecting the resulting acoustic response transverse to that axis. Accordingly, in the arrangement of Fig 1A light energy from a diode laser (not shown) is transmitted via a fibre-optic guide 10 to the tip of a finger 12. The photoacoustic interaction occurs in an approximately cylindrical region indicated at 14 from which acoustic energy is radiated in a generally cylindrical manner and is detected by a transversely arranged acoustic transducer 16.
  • the principle is similar.
  • the finger 12 is pressed against a support with force F.
  • the incident light beam indicated at L is directed as in Fig 1A, and the transducer 16 is at an angle of 45 degrees thereto.
  • the angle is 90 degrees as in Fig 1A, but the incident beam is directed differently into the fingertip.
  • the laser wavelength is chosen to achieve high degree of absorption by glucose present in the blood.
  • a suitable wavelength is in the range approximately 1000 to 3000 nm.
  • the laser pulse duration is chosen to be short, typically of the order of 5 to 500 ns, in order to minimise thermal diffusion and thus to optimise the acoustic waveform.
  • it is desirable to use a spot size which is sufficiently small to minimise thermal diffusion typically a spot size of the order of 0.05 mm to 0.50 mm.
  • the efficiency of the photoacoustic detection is also influenced by the positioning and dimensions of the acoustic transducer in relation to the characteristic extinction length of the tissue at the principal wavelengths chosen for measurement.
  • the system efficiency will be improved by optimising the length of the transducer crystal parallel to the axis of the finger, but the length should not be so great as to give rise to undesired signals which would occur at the point of entry of the optical energy into the finger and by reason of interaction of the acoustic energy with bone or other hard tissue.
  • a second limit on the size of the acoustic detector derives from the wavelength of the acoustic wave in the tissue. Again making use of Huyghens principal of superposition we view each point of tissue, that is illuminated by the incoming light, as a point source that generates a spherical pressure wave. The signal measured at the detector is just the superposition of all pressure waves from all points that are illuminated by the source light. Normally if the size of the detector is increased then the signal should also increase because more energy is received by the detector. However if the acoustic detector is too large then a pressure wave generated from a tissue element will create a pressure wave that will strike the both ends of the detector.
  • the path length from the tissue element to the first end of the detector is different than the path length to the second end of the detector and if this difference in path length is about one half of the acoustic signal wavelength then the signal will destructively interfere with itself and will reduce the magnitude of the measured signal.
  • a sensor head having a finger rest 18 which is slidably moveable within housing 20 closed by a front plate 22.
  • the user inserts his finger in a semi-cylindrical depression 24 in the finger rest 18 with the finger tip engaged against an end surface 28 which includes an exit face 26 of the optical fibre 10.
  • the finger is then pressed downwardly against a resilient bias to enable a standardised contact to be obtained between the skin and the acoustic transducer.
  • the finger tip may first be dipped in water or coated with an aqueous gel to improve the acoustic coupling.
  • the acoustic transducer comprises a semi- cylindrical piezoelectric transducer 30.
  • the transducer 30 is provided with a backing member 32 of lead or another dense substance, the rear face 34 of which is shaped in irregular curves.
  • the use of the semi-cylindrical transducer 30 maximises the area for reception of acoustic energy from the finger, while the use of a dense backing material minimises ringing effects within the transducer.
  • the rear face 34 is shaped as shown to reduce reflection of acoustic energy back towards the piezo crystal.
  • Fig 3 also shows the finger rest biased upwardly by the use of constant tension springs 38.
  • Fig 5 illustrates schematically the apparatus of Figs. 2 and 3 embodied in a self-contained, portable blood monitoring apparatus including a user readout 40.
  • An apparatus of this nature allows a diabetic to monitor blood glucose concentration in a convenient manner, as frequently as may be desired, and in a painless and discreet manner.
  • FIG. 6 shows an arrangement in which a light guide 50 and an acoustic transducer 52 are applied to a finger 54 by means of a hinged clamp member 56.
  • Fig. 7 shows a finger 60 engaged by a light guide 62 and an acoustic transducer 64 which are carried on a moveable assembly 66 with the finger 60 being trapped between the moveable assembly 66 and a fixed anvil 68.
  • Figs. 8a and 8b show an arrangement in which a cup shaped member 70, suitably of rubber, causes a light guide 72 and an acoustic transducer 74 to be contacted with a bulge of soft tissue 76 which may for example be drawn into contact by means of a partial vacuum within the member 70 caused by suction through a conduit 78, or by other mechanical or adhesive means.
  • a planar mount 80 carrying a light guide 82 and acoustic transducer 84 is secured to a soft area of body by means of surgical adhesive 86.
  • one method of performing measurement on an ear lobe involves placing the ear lobe between a fixed plate 87 and a movable plate 88.
  • the acoustic detector 89 is mounted partially perpendicular that is at an acute angle, to the beam axis defined as line going from the center of a lens 90 to the center of a window 91. It has been found that the system works satisfactorily with the detector 89 at an angle or 45° to the beam axis.
  • the window 91 and the detector 89 are placed in direct contact with the ear and the opposite plate 88 places pressure on the ear using a suitable mechanism (not shown) .
  • This particular embodiment of the ear interface apparatus incorporates an alignment ring 92 which is temporarily attached to the ear and fits over the window housing 91 to aid in aligning ear into the same location every time.
  • one method of combining light sources into the instrument is to use a mechanical housing 93 with several holes used to align lenses 95 and laser diodes 94.
  • the housing shown uses a hexagonal array of seven holes.
  • the sources and lenses are arranged in such a way that they all focus to the same location 96 which could be on the surface of the body part. This design does not show the inclusion of beamsplitters and reference detectors but they can be added in an alternative arrangement.
  • FIG. 12 An alternative method of combining several sources into one beam is shown in Fig. 12.
  • Several laser diodes 97 are shown coupled to individual fiber optic cables 131. These cables 132 are combined using a fiber Wavelength Division Multiplexer (WDM) 98.
  • WDM Wavelength Division Multiplexer
  • the combined light exits the WDM 98 in a single fiber 104 and terminates at the focal point of a a. lens 131. This end of the fiber is imaged to the end of the finger 103 to a spot 102 using another lens 130.
  • Some of the light is split off the main beam using a beam splitter 100 and focused onto a reference detector 101 using another lens 99. Additional reference detectors and/or beamsplitters can be added to the distribution system without changing its function. Alternatively a reference detector could look directly at the body part to measure the light reflecting off the surface, as a measure of the overall light energy entering the body part.
  • FIG. 13 another method of using a finger as the body part and including removable inserts is shown.
  • a finger 105 is inserted into an insert 106 that is used to customize the finger holder to a particular finger.
  • the moulded insert 106 is placed into a housing 107.
  • the finger 105 is placed against a semi-cylindrical acoustic detector in a modulel08 which is also attached to the housing 107.
  • a cover 109 for the housing 107 contains a mechanism 111 to apply constant force to the finger 105.
  • the light beam 110 is introduced into the finger 105 using a suitable optical distribution system (not shown) .
  • Fig. 13A shows the module 108 in greater detail.
  • a base 200 carries a part-cylindrical piezo transducer 202 on a support 204.
  • 206 indicates a coaxial connector to communicate the transducer signal.
  • Fig. 14 shows a schematic of an alternative to the vacuum arrangement shown in Figs. 8 and 9.
  • a photoacoustic reader 121 is placed against the skin 113 with a semi-spherical detector 112 in contact with the skin 113.
  • a vacuum pump 115 and vacuum seal 116 create a negative pressure and pull the skin 113 against the detector 112.
  • Processing electronics 119 a. energizes light sources 118 and an optical distribution system 117 routes the light to the body part through a hole in the top of the semi-spherical detector 112.
  • the optical distribution system 117 directs a small portion of the light to a reference detector 114.
  • the processing electronics 119 measures the signal from the acoustic detector 112 and the reference detector 114 for each optical source 119 and calculates the glucose value.
  • the value is displayed on a display 120.
  • Fig. 15 shows a similar system 125, only using another type of optical distribution system 127.
  • a vacuum pump 123 creates a negative pressure which draws the skin up to an acoustic detector 122.
  • Processing electronics 124 signals light sources in optical distribution system 127 to illuminate and a signal is generated at acoustic detector 122.
  • the processing electronics 124 calculates the proper value and displays it on a display 126.
  • Fig. 16 shows an alternative arrangement of a photo- acoustic reader.
  • the vacuum system is replaced with an ear squeeze mechanism 129 which applies pressure to the ear.
  • An acoustic detector 130 detects the signals from the ear lobe.
  • a single analyte such as glucose in blood can be measured by using light of selected wavelengths and by measuring the area or the amplitude of the received acoustic pulse. It is preferable to make each measurement by using a train of pulses, for example about 100 pulses, and averaging the results in order to minimise the effects of noise and pulse effects in the blood flow.
  • the accuracy of the detection system is governed, in part, by the Signal to Noise Ratio (SNR) of the system.
  • SNR Signal to Noise Ratio
  • Variations in the intensity and duration of the light source can cause the acoustic signal to contain variations.
  • a normalization technique such as taking the ratio of the acoustic signal to the optical signal, can significantly reduce the effect of the source variations, thereby improving the signal to noise ratio of the system.
  • the optical signal can be measured with a reference detector, or several reference detectors, one for each source or one for a wavelength range. An equation describing this type of normalization follows:
  • the relationship between the optical signal land the acoustic signal changes with wavelength and light intensity.
  • the accuracy of the measurement can be further enhanced by determining the energy dependence of the photoacoustic signal. This may be determined by establishing the specific relationship between the photoacoustic signal land the incident energy from a set of measurements and using this relationship to compensate for the non linear response.
  • An equation describing this type of normalization is as follows:
  • the time interval between the optical pulse and the detection of the acoustic signal may be used to characterise physical properties such as the velocity of sound in the tissue.
  • the damping of the acoustic oscillations may be used to monitor the elastic properties of the tissue and, in particular, the compressibility. Both of these aspects may be used in the person to person calibration of the photoacoustic response.
  • a time-gating technique may be used to derive measurement at varying depths within the tissue being examined.
  • an array of detectors can be employed to determine the profile of the absorption of the acoustic signal at different depths and locations. This depth profile will change with the absorption coefficient and could be used as additional information to determine the analyte concentration.
  • multiple light sources can aid in the determination of the concentration of a number of analytes.
  • tissue features which may vary from person to person or with in the same person over time which impact the photoacoustic signal observed.
  • analyte such as glucose
  • haemoglobin which may act as interferants .
  • One approach is to generate several distinct photoacoustic signals using excitation light of several different wavelengths. For example, excitation light of a wavelength of which haemoglobin absorbs strongly but glucose has little if any absorption could be sued to obtain a measure of the haemoglobin concentration with which to normalize the effect of haemoglobin on measurements made on different persons or on the same person at different times.
  • excitation light of a wavelength of which haemoglobin absorbs strongly but glucose has little if any absorption could be sued to obtain a measure of the haemoglobin concentration with which to normalize the effect of haemoglobin on measurements made on different persons or on the same person at different times.
  • These measurements which are to be normalized might be based on the photoacoustic signal generated
  • the concentration of such interferants by other means, such as infrared light absorption, and thus normalize or correct the photoacoustic signal representative of the desired analyte for variations in these interferants.
  • the photoacoustic signal representative of glucose could be corrected for variations in haemoglobin concentration determined by optical absorption techniques such as those taught in US Patent No 5,702,284.
  • a signal to noise ratio of at least 10,000 is recommended.
  • water is typically present in human tissue of a concentration of about 50 molar while glucose is present at a concentration of about 5 millimolar in a normal individual.
  • Apparatus and method embodying the present invention have been found to yield accurate and repeatable results.
  • the clinical range of glucose concentration is approximately 5-10 m mol/1 in healthy subjects, and up to 40 m mol/1 in diabetics.
  • An analysis based on simple absorption models suggests that the change in photoacoustic signal over this range might be as little as 0.2%.
  • the present invention has been found to provide a change in photoacoustic signal of up to 140% for a change in glucose concentration of 15m mol/1.
  • the resulting photoacoustic signal was detected by a 5mm disc transducer with a lead backing and fed to an amplifier and an oscilloscope.
  • the transducer was generally placed as 16 in Figure 1 but was not precisely parallel to the beam axis; its detection plane was at an angle of about 20 degrees to the beam axis .
  • the photoacoustic signal was evaluated in terms of the difference in voltage signal from the positive peak of the compression to the negative peak of the relaxation of the acoustic pulse. a.

Abstract

A biological parameter such as blood glucose is measured by directing laser pulses from a light guide (10) into a body part consisting of soft tissue, such as the tip of a finger (12) to produce a photoacoustic interaction. The resulting acoustic signal is detected by a transducer (14) and analysed to provide the desired parameter.

Description

Biological Measurement System
This invention relates to apparatus for use in non- invasive in vivo monitoring of physiological substances such as blood and the like.
One particular, but not exclusive, application of the present invention is in the monitoring of blood glucose, for example in the management of diabetes mellitus. It is accepted that the management of diabetes can be much improved by routine monitoring of blood glucose concentration and clinicians suggest that monitoring as often as four times per day is desirable.
The monitoring technique currently available for use by patients involves using a spring loaded lancet to stab the finger to obtain a blood sample which is transferred to a glucose test strip. The concentration is derived either by reading the test strip with a reflectance meter or by visual comparison of colour change against a colour scale. Many diabetics find the testing onerous as the technique is painful, inconvenient, messy, potentially embarrassing and offers a site for the transmittance and acceptance of infection. Techniques have also been developed for non invasive measurement using transmittance or reflectance spectroscopy . However the required instruments are expensive and it is difficult to obtain accurate and repeatable measurements .
There are also known various types of in vivo chemical sensors. These rely on implanting minimally invasive sensors under the skin surface, but such sensors have poor long term reproducibility and bio-compatibility problems.
There is therefore a need for improved means for routine monitoring of blood glucose in a manner which is simple and straightforward to use.
The present invention makes use of photoacoustic techniques. The fundamentals of photoacoustic techniques are well known per se. A pulse of light, typically laser light, is applied to a substance containing an analyte of interest in solution or dispersion, the wavelength of the applied light being chosen to interact with the analyte. Absorption of the light energy by the analyte gives rise to microscopic localised heating which generates an acoustic wave which can be detected by an acoustic sensor. These techniques have been used to measure physiological parameters in vitro.
US Patents 5348002 and 5348003 (Caro) propose the use of photoacoustics in combination with photoabsorption for the measurement of blood components in vivo. However, the arrangement proposed by Caro has not been demonstrated as a workable system and may suffer from interference to a degree which would preclude useful acoustic signals, and since they would also suffer from interference and resonance effects from hard structures such as bone.
It has also been proposed by Poulet and Chambron in Medical and Biological Engineering and Computing, November 1985, Page 585 to use a photoacoustic spectrometer in a cell arrangement to measure characteristics of cutaneous tissue, but the apparatus described would not be suitable for measuring blood analytes.
Published European Patent Application 0282234A1 (Dowling) proposes the use of photoacoustic spectroscopy for the measurement of blood analytes such as blood glucose. This disclosure however does not show or suggest any means which would permit the required degree of coupling to body tissues for use in vivo.
Accordingly, the present invention provides a sensor head for use in photoacoustic in vivo measurement, comprising a housing shaped to engage a selected body part, light transmission means terminating in said housing so as to transmit light energy from a light source to enter the body part along a beam axis, and acoustic transducer means mounted in the housing to receive acoustic waves generated by photoacoustic interaction within the body part, the acoustic transducer means being disposed in the housing to receive said acoustic wave in a direction of high acoustic energy.
The expression "direction of high acoustic energy" is used herein to denote a direction other than the forward direction of the light beam. Preferably, the transducer means is disposed so as to intercept acoustic energy propagating at right angles to the optical beam axis, or at an angle to the optical beam axis which may be down to about 20°, typically about 45°.
An exact measure of the angle of high acoustic energy a. can be worked out but is dependent upon the specific geometry of the light source, the properties of the tissue and the absorption coefficient of the tissue. One model for understanding the propagation of the acoustic energy in any homogenous media was developed by Huyghens and is called the principle of superposition. In this model each volume element that is illuminated by the light generates an acoustic pressure wave that radiates outward in a spherical manor. The magnitude of the pressure wave at each volume element depends on the intensity of the optical beam at that location, the absorption coefficient of the material at that location, the wavelength of light and on several other physical properties of the material such as the speed of sound and the specific heat. The signal measured at the detector is just the superposition of all pressure waves from all points that are illuminated by the source light. An analytical solution for the pressure wave has been worked out for a few cases in aqueous material. The analytical case that best matches the in-vivo measurements is that of a cylindrical optical beam propagating in a weekly absorbing material. In this case the direction of highest acoustic energy is perpendicular to the optical axis. The base detector location is with the plane of the detector perpendicular to the acoustic energy, or parallel to the optical axis. This is because the acoustic detector has the highest sensitivity when the acoustic energy strikes the detector perpendicular to the plane of the detector. This analytical model is not completely accurate for the in-vivo measurement case because of scattering of the tissue and because the tissue absorbs more than the model predicts. These differences indicate that a different position for the detector will be optimal. A detailed numeric model is required to determine the best detector location and is dependent upon the beam properties (focused to a point, colligated, etc.), body site (finger, earlobe, arm etc.) and wavelength. One skilled in the art can readily develop an appropriate mode. However, suitable locations for a detector will generally be at an angle to the optical axis. Angles between 40 and 90 degrees should be suitable.
In one preferred arrangement, the acoustic transducer means is arranged parallel to the optical beam axis. This arrangement is particularly suitable for use where the selected body part is the distal portion of a finger, in which case the housing may include a generally half-cylindrical depression in which the finger may be placed with the light transmission means aimed at the end of the finger.
Preferably, the acoustic transducer means comprises a piezoelectric transducer which most preferably is of a semi-cylindrical shape. This transducer may be provided with a backing of lead or other dense material, and the backing may have a rear surface shaped to minimise internal acoustic reflection.
Alternative transducer means include a capacitor-type detector, which is preferably small and disk-shaped; an integrated semiconductor pressure sensor; and an optical pressure sensor, for example based on an optical fibre. In an alternative arrangement, the plane of the transducer may be arranged to be perpendicular to the optical axis to detect the acoustic wave which is propagating in a direction opposite to the direction of the light beam. For example, the acoustic transducer means may be part-spherical with an aperture to allow access for the light beam. This may be particularly suitable for engagement with a body part other than the finger, for example the back of the arm.
The generation of a surface acoustic wave is an inherent aspect of the in vivo pulsed photoacoustic generation in tissue and may be used to characterize tissue properties such as density. A surface wave detector may be provided in the sensing head assembly.
Preferably means are provided for ensuring a consistent contact pressure between the selected body part and the acoustic transducer means. In the case where the selected part is the distal portion of the finger, said means may be provided by mounting the portion of the housing engaged by the finger in a resiliently biased fashion against the remainder of the housing, and providing means to ensure that measurement is effected when the predetermined force or pressure is applied by the subject against the resilient bias. In the case where the selected part is the earlobe, said means may be provided by placing the ear between two plates and applying pressure to the ear with springs or weights or other force method. The two plates holding the ear may contain a removable insert. The two plates may be flat or may be of another shape to optimally position the detector with respect to the beam axis.
In addition, the present invention provides a sensor head for use in photoacoustic in-vivo measurements, comprising a housing shaped to receive a removable insert, a removable insert that engages a selected body part, the insert being fitted to an individual, allowing for a range of sizes of body parts to be used, and further comprising light transmission means terminating in or near said removable insert so as^ to transmit light energy from a light source or sources to enter the body part along a beam axis, and an acoustic transducer means mounted in the housing or in the removable insert to receive acoustic waves generated by photoacoustic interaction within the body part to receive said acoustic waves in a direction of high acoustic energy.
From another aspect the present invention provides an in vivo measuring system comprising a sensor head as hereinbefore defined in combination with a light source coupled with the light transmission means, and signal processing means connected to receive the output of the acoustic transducer means and to derive therefrom a measurement of a selected physiological parameter.
Preferably, the light transmission means is a fiber distribution system where each light source is connected to an individual fiber and when multiple light sources are used the multiple fibres are joined by some standard fiber combining method, such as a wavelength division multiplexer or a fiber coupler. The fiber that comes from the light source, or contains the combined light for a multiple source system, is then terminated in proximity to the body part being measured. The fiber could be in contact with the body part or alternatively standard optics, such as lenses, beamsplitters and such, could be employed to convey the light from the end of the fiber to the body part. A reference detector or several reference detectors and beamsplitters can be added to the optical distribution system to determine the energy of the light entering the body part.
Alternatively, the optical distribution system may contain mechanical holders, lenses and such to convey the light from the source, or sources, to a location in proximity to the body part being measured. A reference detector or several reference detectors and beamsplitters can be added to the optical distribution system to determine the energy of the light entering the body part.
The acoustic signal from the detector contains information in both time and frequency, and there may be information from several sources. The processing means is preferably a multi-dimensional processing method, such as Classical Least Squares (CLS) or Partial Least Squares (PLS). Alternatively the processing method may be more flexible, such as a Neural Network. In addition to these methods the signals may be analysed for their frequency content using such techniques as Fourier Analysis or Frequency Filtering In addition techniques may be employed that use time information such as the time delay from source trigger. Techniques that combine both frequency and time information may be employed, such as Wavelet analysis.
The light source is preferably a laser light source and is most suitably a pulsed diode laser, but may utilise a set of such lasers or utilise a tunable laser source. In a particularly preferred form, suitable for use in measuring blood glucose concentration, a laser diode is used with a wave length in the range of approximately 600 nm to 10,000 nm and a pulse duration of the order of 5 to 500 ns.
The delivery to the measurement site may be either directly or by optical fibre with a suitable optical element to focus the beam into the tissue.
Preferably means are provided for time multiplexing multiple sources when multiple sources are used. Each source is switched on, and it generates an optical pulse, or a set of optical pulses. This pulse, or set of pulses, generates an acoustic signal that is detected by the detector. Each source is pulsed in sequence until all sources have been used to generate their own signal.
The measuring system may conveniently be in the form of a self contained system including a power supply and a readout, which may be carried on the person and used at any convenient time.
It is also possible for such a self contained system to incorporate, or to be provided with facilities for connection to, a cellular telephone, two-way pager or other communication device for routine transmission of measurements taken to a central data collection point.
In addition the measuring system may have provision for manipulating the body part under measurement and for performing additional measurement of the tissue to get other information about the state of the physiology of the issue. It is well-known in the art that squeezing a section of tissue to increase the pressure and then releasing the pressure will cause changes in the total blood volume in the measurement site. The present invention may allow for this type of manipulation including the squeezing of a body part, such as an earlobe, and making photo acoustic measurements at several different pressures. The present invention may also allow for the measurement of the temperature of the body site and to apply a correction to the measurements based upon the temperature of the body site.
Another type of physiological manipulation is body temperature. It is known in the art that several parameters involved in the detection of the photo acoustic signal, such as the speed of sound, are dependent upon the temperature of the medium the signal is propagating through (the tissue). Also the profusion of the blood in the small capillaries is dependent upon the temperature of the tissue. Additional information about the tissue can be obtained if the photo acoustic measurement is made at several temperatures, both higher and lower than ambient temperature. This additional information is used to better eliminate interferences to the determination of the analyte under investigation. These are only two examples of manipulating the body site and are not intended to be an exhaustive list, and they can be used in combination with other manipulation techniques.
The in-vivo measuring system may comprise a means for storing calibration coefficients or operation parameters or both calibration coefficients and operational parameters, in order to calibrate the instrument and to set critical operational parameters.
Another aspect of the present invention provides a means for adjusting the calibration coefficients and operational parameters to be specific to a particular person and may be used to adjust for such things as body part size, skin color, skin condition, amount of body fat, efficiency of the detector and efficiency of the source ( s ) .
In addition the present invention may provide for having the specific calibration coefficients and operational parameters be contained in a storage site located in the removable insert. This allows for the system to be both mechanically and operationally configured to a particular individual. Additionally the invention may allow for the calibration coefficients and operational parameters to be stored in two locations, one in the non-removable housing and one in the removable insert with some of the coefficients and parameters stored in each location. This allows for reader system coefficients to be stored in the reader and coefficients specific to an individual to be stored in the removable insert for that person, enabling many people to use the same reader.
Another aspect of the present invention provides means for connecting the non-invasive measuring system to an invasive measuring system for the purpose of calibrating or adjusting the operational parameters of the non-invasive measuring system. Such connection may be accomplished, but is not limited to, communication by a wire, IR link or radio waves.
Another aspect of the present invention provides a method for removing instrument drift from the measurement comprising the steps of:
1. Placing a standard in the reader in place of the body part.
2. Measuring the signal from the standard for each wavelength and storing the values in the calibration storage location.
3. Before making a measurement of a body part, placing the calibration standard in the reader.
4. Measuring the signal from the standard for each source.
5. Comparing the just measured standard values to the stored calibration values.
6. Calculating correction factors for each source wavelength.
7. Removing the standard and placing the body part in the reader.
8. Measuring the signal from the body part for each source.
9. Adjusting the measured values using the calculated correction factors.
In addition to the signal correction factors a correction factor can be calculated for the instrument temperature. This can be applied to each signal with a different correction coefficient.
The invention further provides a method of measuring a biological parameter in a subject, the method comprising the steps of:
directing one or more pulses of optical energy from the exterior into the tissue of a subject along a beam axis, the optical energy having a wavelength selected to be absorbed by tissue components of interest, thereby to produce a photoacoustic interaction;
detecting acoustic energy resulting from said photoacoustic reaction by means of a transducer positioned to intercept acoustic energy propagating in a direction other than the forward direction of said beam axis; and
deriving from said detected acoustic energy a measure of the parameter of interest; and a corresponding apparatus.
Embodiments of the invention will now be described, by way of example only, with reference to the accompanying drawings in which: -
Figs. 1A,1B and IC are side views illustrating the principle of operation of one embodiment of the present invention;
Fig. 2 is a schematic perspective view showing a sensor head for use in carrying out the measurement illustrated in Fig. 1;
Fig 3. is a cross section view of the sensor head of Fig. 2;
Fig. 4 is a side view of the sensor head of Fig. 2;
Fig. 5 is a schematic perspective view of an apparatus incorporating the sensor head of Figs. 2 to 4; Fig. 6 is a perspective view illustrating an alternative form of sensor head;
Fig. 7 is a schematic end view showing another form of sensor head;
Figs. 8a and 8b are a cross-sectional side view and a plan view, respectively, of a further sensor head;
Fig. 9 is a cross-sectional side view of one more embodiment of sensor head;
Fig. 10 is a perspective view of one type of ear interface apparatus;
Fig. 11 is a schematic of a multiple laser optical distribution system using lenses, mechanical mounts and a reference detector;
Fig. 12 is a schematic of a multiple laser optical distribution system using fiber optic cables and a fiber Wavelength Division Multiplexer (WDM), a beam splitter and a reference detector;
Fig. 13 is a perspective view of a finger interface apparatus with removable inserts that are moulded to fit one individual;
Fig. 13A shows part of the apparatus of Fig. 13 in greater detail;
Fig. 14 is a schematic of a semi-spherical detector that contains a hole for the light beam, with a vacuum system and a fiber distribution system; Fig. 15 is a perspective view showing one form of the instrument utilizing the vacuum body interface, a semi-spherical detector and the multiple laser source with lenses and mechanical housing;
Fig. 16 is a perspective view showing one form of the instrument using an ear lobe body interface, with the added feature of being able to manipulate the pressure on the ear lobe; and
Figs. 17, 18 and 19 are graphs illustrating an example.
Referring to Fig 1, an important feature of the present invention lies in introducing light energy along an axis into an area of soft tissue and detecting the resulting acoustic response transverse to that axis. Accordingly, in the arrangement of Fig 1A light energy from a diode laser (not shown) is transmitted via a fibre-optic guide 10 to the tip of a finger 12. The photoacoustic interaction occurs in an approximately cylindrical region indicated at 14 from which acoustic energy is radiated in a generally cylindrical manner and is detected by a transversely arranged acoustic transducer 16.
In Figs IB and IC, the principle is similar. The finger 12 is pressed against a support with force F. In Fig IB, the incident light beam indicated at L is directed as in Fig 1A, and the transducer 16 is at an angle of 45 degrees thereto. In Fig IB, the angle is 90 degrees as in Fig 1A, but the incident beam is directed differently into the fingertip. In the present embodiment, the laser wavelength is chosen to achieve high degree of absorption by glucose present in the blood. A suitable wavelength is in the range approximately 1000 to 3000 nm. The laser pulse duration is chosen to be short, typically of the order of 5 to 500 ns, in order to minimise thermal diffusion and thus to optimise the acoustic waveform. For the same reasons, it is desirable to use a spot size which is sufficiently small to minimise thermal diffusion, typically a spot size of the order of 0.05 mm to 0.50 mm.
The efficiency of the photoacoustic detection is also influenced by the positioning and dimensions of the acoustic transducer in relation to the characteristic extinction length of the tissue at the principal wavelengths chosen for measurement. In the fingertip arrangement of Fig. 1, the system efficiency will be improved by optimising the length of the transducer crystal parallel to the axis of the finger, but the length should not be so great as to give rise to undesired signals which would occur at the point of entry of the optical energy into the finger and by reason of interaction of the acoustic energy with bone or other hard tissue.
A second limit on the size of the acoustic detector derives from the wavelength of the acoustic wave in the tissue. Again making use of Huyghens principal of superposition we view each point of tissue, that is illuminated by the incoming light, as a point source that generates a spherical pressure wave. The signal measured at the detector is just the superposition of all pressure waves from all points that are illuminated by the source light. Normally if the size of the detector is increased then the signal should also increase because more energy is received by the detector. However if the acoustic detector is too large then a pressure wave generated from a tissue element will create a pressure wave that will strike the both ends of the detector. If the paths length from the tissue element to the first end of the detector is different than the path length to the second end of the detector and if this difference in path length is about one half of the acoustic signal wavelength then the signal will destructively interfere with itself and will reduce the magnitude of the measured signal.
Referring to Fig 2, one manner of carrying out the arrangement shown in Fig 1 makes use of a sensor head having a finger rest 18 which is slidably moveable within housing 20 closed by a front plate 22. The user inserts his finger in a semi-cylindrical depression 24 in the finger rest 18 with the finger tip engaged against an end surface 28 which includes an exit face 26 of the optical fibre 10. The finger is then pressed downwardly against a resilient bias to enable a standardised contact to be obtained between the skin and the acoustic transducer. The finger tip may first be dipped in water or coated with an aqueous gel to improve the acoustic coupling.
Referring to Figs 3 and 4, in this preferred arrangement the acoustic transducer comprises a semi- cylindrical piezoelectric transducer 30. The transducer 30 is provided with a backing member 32 of lead or another dense substance, the rear face 34 of which is shaped in irregular curves. The use of the semi-cylindrical transducer 30 maximises the area for reception of acoustic energy from the finger, while the use of a dense backing material minimises ringing effects within the transducer. Additionally, the rear face 34 is shaped as shown to reduce reflection of acoustic energy back towards the piezo crystal.
Fig 3 also shows the finger rest biased upwardly by the use of constant tension springs 38.
Fig 5 illustrates schematically the apparatus of Figs. 2 and 3 embodied in a self-contained, portable blood monitoring apparatus including a user readout 40. An apparatus of this nature allows a diabetic to monitor blood glucose concentration in a convenient manner, as frequently as may be desired, and in a painless and discreet manner.
Other forms of photoacoustic sensor head are possible within the scope of the present invention. For example, Fig. 6 shows an arrangement in which a light guide 50 and an acoustic transducer 52 are applied to a finger 54 by means of a hinged clamp member 56. Fig. 7 shows a finger 60 engaged by a light guide 62 and an acoustic transducer 64 which are carried on a moveable assembly 66 with the finger 60 being trapped between the moveable assembly 66 and a fixed anvil 68.
It is also possible to arrange the sensor head to co- operate with a soft tissue surface of the body, for example a soft part of the abdomen. Figs. 8a and 8b show an arrangement in which a cup shaped member 70, suitably of rubber, causes a light guide 72 and an acoustic transducer 74 to be contacted with a bulge of soft tissue 76 which may for example be drawn into contact by means of a partial vacuum within the member 70 caused by suction through a conduit 78, or by other mechanical or adhesive means. A somewhat similar arrangement is shown in Fig. 9 in which a planar mount 80 carrying a light guide 82 and acoustic transducer 84 is secured to a soft area of body by means of surgical adhesive 86.
Referring to Fig. 10, one method of performing measurement on an ear lobe involves placing the ear lobe between a fixed plate 87 and a movable plate 88. The acoustic detector 89 is mounted partially perpendicular that is at an acute angle, to the beam axis defined as line going from the center of a lens 90 to the center of a window 91. It has been found that the system works satisfactorily with the detector 89 at an angle or 45° to the beam axis. The window 91 and the detector 89 are placed in direct contact with the ear and the opposite plate 88 places pressure on the ear using a suitable mechanism (not shown) . This particular embodiment of the ear interface apparatus incorporates an alignment ring 92 which is temporarily attached to the ear and fits over the window housing 91 to aid in aligning ear into the same location every time.
Referring to Fig. 11, one method of combining light sources into the instrument is to use a mechanical housing 93 with several holes used to align lenses 95 and laser diodes 94. The housing shown uses a hexagonal array of seven holes. The sources and lenses are arranged in such a way that they all focus to the same location 96 which could be on the surface of the body part. This design does not show the inclusion of beamsplitters and reference detectors but they can be added in an alternative arrangement.
An alternative method of combining several sources into one beam is shown in Fig. 12. Several laser diodes 97 are shown coupled to individual fiber optic cables 131. These cables 132 are combined using a fiber Wavelength Division Multiplexer (WDM) 98. Alternative combination methods exist including couplers and multi-fiber bundles. The combined light exits the WDM 98 in a single fiber 104 and terminates at the focal point of a a. lens 131. This end of the fiber is imaged to the end of the finger 103 to a spot 102 using another lens 130. Some of the light is split off the main beam using a beam splitter 100 and focused onto a reference detector 101 using another lens 99. Additional reference detectors and/or beamsplitters can be added to the distribution system without changing its function. Alternatively a reference detector could look directly at the body part to measure the light reflecting off the surface, as a measure of the overall light energy entering the body part.
Referring to Fig. 13, another method of using a finger as the body part and including removable inserts is shown. A finger 105 is inserted into an insert 106 that is used to customize the finger holder to a particular finger. The moulded insert 106 is placed into a housing 107. The finger 105 is placed against a semi-cylindrical acoustic detector in a modulel08 which is also attached to the housing 107. A cover 109 for the housing 107 contains a mechanism 111 to apply constant force to the finger 105. The light beam 110 is introduced into the finger 105 using a suitable optical distribution system (not shown) . Fig. 13A shows the module 108 in greater detail. A base 200 carries a part-cylindrical piezo transducer 202 on a support 204. 206 indicates a coaxial connector to communicate the transducer signal.
Fig. 14 shows a schematic of an alternative to the vacuum arrangement shown in Figs. 8 and 9. In this system a photoacoustic reader 121 is placed against the skin 113 with a semi-spherical detector 112 in contact with the skin 113. A vacuum pump 115 and vacuum seal 116 create a negative pressure and pull the skin 113 against the detector 112. Processing electronics 119 a. energizes light sources 118 and an optical distribution system 117 routes the light to the body part through a hole in the top of the semi-spherical detector 112. The optical distribution system 117 directs a small portion of the light to a reference detector 114. The processing electronics 119 measures the signal from the acoustic detector 112 and the reference detector 114 for each optical source 119 and calculates the glucose value. The value is displayed on a display 120.
Fig. 15 shows a similar system 125, only using another type of optical distribution system 127. Again a vacuum pump 123 creates a negative pressure which draws the skin up to an acoustic detector 122. Processing electronics 124 signals light sources in optical distribution system 127 to illuminate and a signal is generated at acoustic detector 122. The processing electronics 124 calculates the proper value and displays it on a display 126.
Fig. 16 shows an alternative arrangement of a photo- acoustic reader. In this system 128, the vacuum system is replaced with an ear squeeze mechanism 129 which applies pressure to the ear. An acoustic detector 130 detects the signals from the ear lobe.
In the most straightforward forms of the invention, a single analyte such as glucose in blood can be measured by using light of selected wavelengths and by measuring the area or the amplitude of the received acoustic pulse. It is preferable to make each measurement by using a train of pulses, for example about 100 pulses, and averaging the results in order to minimise the effects of noise and pulse effects in the blood flow.
The accuracy of the detection system is governed, in part, by the Signal to Noise Ratio (SNR) of the system. Variations in the intensity and duration of the light source can cause the acoustic signal to contain variations. A normalization technique, such as taking the ratio of the acoustic signal to the optical signal, can significantly reduce the effect of the source variations, thereby improving the signal to noise ratio of the system. The optical signal can be measured with a reference detector, or several reference detectors, one for each source or one for a wavelength range. An equation describing this type of normalization follows:
Acoustic Signal Normalized Signal = Optical Signal
In some cases the relationship between the optical signal land the acoustic signal changes with wavelength and light intensity. When this is the case the accuracy of the measurement can be further enhanced by determining the energy dependence of the photoacoustic signal. This may be determined by establishing the specific relationship between the photoacoustic signal land the incident energy from a set of measurements and using this relationship to compensate for the non linear response. An equation describing this type of normalization is as follows:
Acoustic Signal Normalized Signal = Scaling Factor *Optical Signal + Offset
Other normalization methods can also apply. The time interval between the optical pulse and the detection of the acoustic signal may be used to characterise physical properties such as the velocity of sound in the tissue. In addition, in another embodiment of the device the damping of the acoustic oscillations may be used to monitor the elastic properties of the tissue and, in particular, the compressibility. Both of these aspects may be used in the person to person calibration of the photoacoustic response.
More complex analysis of the received acoustic energy is possible. For example, a time-gating technique may be used to derive measurement at varying depths within the tissue being examined. Alternatively, an array of detectors can be employed to determine the profile of the absorption of the acoustic signal at different depths and locations. This depth profile will change with the absorption coefficient and could be used as additional information to determine the analyte concentration. It is also possible to derive information relating to a number of analytes of interest by more sophisticated analysis of the received acoustic energy wave forms, for example by analysis of the frequency spectrum by Fourier transform or wavelet analysis techniques.
Alternatively, or in combination with the frequency techniques and multiple detectors, multiple light sources can aid in the determination of the concentration of a number of analytes.
There are a number of tissue features which may vary from person to person or with in the same person over time which impact the photoacoustic signal observed. To obtain an accurate measurement of a given analyte, such as glucose, it may be helpful to also determine the concentration of other analytes such as haemoglobin which may act as interferants . One approach is to generate several distinct photoacoustic signals using excitation light of several different wavelengths. For example, excitation light of a wavelength of which haemoglobin absorbs strongly but glucose has little if any absorption could be sued to obtain a measure of the haemoglobin concentration with which to normalize the effect of haemoglobin on measurements made on different persons or on the same person at different times. These measurements which are to be normalized might be based on the photoacoustic signal generated by light of a wavelength at which glucose absorbs.
It is also possible to measure the concentration of such interferants by other means, such as infrared light absorption, and thus normalize or correct the photoacoustic signal representative of the desired analyte for variations in these interferants. Thus, for example, the photoacoustic signal representative of glucose could be corrected for variations in haemoglobin concentration determined by optical absorption techniques such as those taught in US Patent No 5,702,284.
For the reliable and reproducible determination of glucose a signal to noise ratio of at least 10,000 is recommended. In this regard water is typically present in human tissue of a concentration of about 50 molar while glucose is present at a concentration of about 5 millimolar in a normal individual. Apparatus and method embodying the present invention have been found to yield accurate and repeatable results. In the case of blood glucose measurement, the clinical range of glucose concentration is approximately 5-10 m mol/1 in healthy subjects, and up to 40 m mol/1 in diabetics. An analysis based on simple absorption models suggests that the change in photoacoustic signal over this range might be as little as 0.2%. The present invention has been found to provide a change in photoacoustic signal of up to 140% for a change in glucose concentration of 15m mol/1.
The precise mechanisms involved are not at present fully understood. It is believed, however, that absorption occurs primarily in body plasma and is modified by the presence of glucose, and that this affects beam geometry.
Example
The blood glucose levels of three individuals, one normal individual, one type 1 diabetic and one type 2 diabetic, were followed over a two hour period following each individual taking about 75 grams of glucose orally in an aqueous solution by both photoacoustics and direct blood measurement. The results are reported in Figures 17, 18 and 19. Photoacoustic measurements were made every five minutes and blood measurements were made very ten minutes. The blood samples were venous blood samples analysed by the standard glucose oxidase method using a Yellow Springs instrument. The error bands for the blood measurements were derived from the literature accompanying the testing instrument while those for the photoacoustic results were based on the averages taken over 1000 pulses. The results were obtained from a configuration similar to that illustrated in Figure 1 in which 10 was an end of a 1 km multimode fibre optic cable which was placed against the finger 12. The other end received 600 nanosecond pulses of 1040 nanometer light from a Q switched Nd:YAG laser delivering 2,7 micro joules per pulse for each measurement. Raman interactions in the fibre caused the production of light an additional wavelengths as set forth in the following table:
Figure imgf000028_0001
The resulting photoacoustic signal was detected by a 5mm disc transducer with a lead backing and fed to an amplifier and an oscilloscope. The transducer was generally placed as 16 in Figure 1 but was not precisely parallel to the beam axis; its detection plane was at an angle of about 20 degrees to the beam axis . The photoacoustic signal was evaluated in terms of the difference in voltage signal from the positive peak of the compression to the negative peak of the relaxation of the acoustic pulse. a.
The change in photoacoustic response correlated well with the change in blood glucose concentration over the two hour measurement period. A correlation of 0.89 was achieved on samples ranging from 4 to 35 m mol/1.
Other modifications and improvements may be made to the foregoing embodiments within the scope of the present invention as defined in the claims.

Claims

1. A sensor head for use in photoacoustic in vivo measurement, comprising a housing shaped to engage a selected body part, light transmission means terminating in said housing so as to transmit a. light energy from a light source to enter the body part along a beam axis, and acoustic transducer means mounted in the housing to receive acoustic waves generated by photoacoustic interaction within the body part, the acoustic transducer means being disposed in the housing to receive said acoustic wave in a direction of high acoustic energy.
2. A sensor head according to claim 1, in which the acoustic transducer means is arranged at least partially perpendicular to the optical beam axis.
3. A sensor head according to claim 2, for use where the selected body part is the distal portion of a finger, in which the housing includes a generally half-cylindrical depression in which the finger may be placed with the light transmission means aimed at the end of the finger.
4. A sensor head according to any preceding claim, in which the acoustic transducer means comprises a piezoelectric transducer which is of a semi- cylindrical shape.
5. A sensor head according to any preceding claim, in which the acoustic transducer means comprises a piezoelectric transducer which is provided with a backing of lead or other dense material.
6. A sensor head according to claim 5, in which said backing has a rear surface shaped to minimise internal acoustic reflection.
7. A sensor head according to any of claims 1 to 4 , in which the transducer means comprises a capacitor-type detector.
8. A sensor head according to any of claims 1 to 4 , in which the transducer means comprises a piezoelectric transducer arranged generally perpendicular to the optical axis to detect the acoustic wave which is propagating in a direction opposite to the direction of propagation of the light beam.
9. A sensor head according to claim 8, in which the transducer is part-spherical with an aperture to allow access for the light beam.
10. A sensor head according to any preceding claim, including a surface wave detector for characterizing tissue properties.
11. A sensor head according to any preceding claim, including means for ensuring a consistent contact pressure between a selected body part and the acoustic transducer means.
12. A sensor head according to claim 11, for use where the selected part is the distal portion of a finger, said means being provided by mounting a portion of the housing engaged by the finger in a resiliently biased fashion against the remainder of the housing, and providing means to ensure that measurement is effected when a predetermined force or pressure is applied by the subject against the resilient bias.
13. A sensor head according to claim 11, for use where the selected part is the earlobe, said means being provided by two plates, between which the earlobe a. may be placed, and means for pressing the plates together to apply pressure to the ear.
14. A sensor head for use in photoacoustic in-vivo measurements, comprising a housing shaped to receive a removable insert; a removable insert that engages a selected body part, the insert being fitted to an individual, allowing for a range of sizes of body parts to be used; light transmission means terminating in or near said removable insert so as to transmit light energy from a light source to enter the body part along a beam axis; and an acoustic transducer means mounted in the housing or in the removable insert to receive acoustic waves generated by photoacoustic interaction within the body part, the acoustic transducer means being disposed in the housing or insert to receive said acoustic waves in a direction of high acoustic energy.
15. An in vivo measuring system comprising in combination: a sensor head as claimed in any preceding claim; a light source coupled with the light transmission means; and signal processing means connected to receive the output of the acoustic transducer means and to derive therefrom a measurement of a selected physiological parameter.
16. The system of claim 15, in which the light transmission means is a fiber optic distribution system.
17. The system of claim 16, in which there is a plurality of light sources each connected to an individual fiber and the respective fibers are a, joined by a wavelength division multiplexer or a fiber coupler.
18. The system of claim 16 or claim 17, in which the fiber optic distribution system terminates in contact with the body part.
19. The system of claim 16 or claim 17, in which the fiber optic distribution system communicates with the body part via optical elements such as lenses and beamsplitters.
20. The system of claim 15, in which the light transmission means comprises optical elements mounted in mechanical holders and arranged to convey the light from the light source to a location in proximity to the body part.
21. The system of claim 19 or claim 20, in which the light transmission means includes at least one beamsplitter arranged in the light path to direct a portion of the light to a respective reference detector to measure the energy of the light entering the body part.
22. The system of any of claims 15 to 21, in which the signal processing means is adapted to perform a multi-dimensional processing method.
23. The system of claim 22, in which the signal processing means is adapted to perform one of Classical Least Squares or Partial Least Squares.
24. The system of any of claims 15 to 21, in which the signal processing means comprises a Neural a, Network .
25. The system of any of claims 15 to 24, in which the signal processing means is operable to analyse the signals for their frequency content using one of Fourier Analysis and Frequency Filtering.
26. The system of any of claims 15 to 25, in which the signal processing means additionally applies techniques that use time information.
27. The system of claim 26, in which the time information processed is the time delay from source trigger.
28. The system of any of claims 15 to 25, in which the signal processing means additionally applies techniques that combine both frequency and time information.
29 The system of claim 28, in which the signal processing means performs wavelet analysis.
30. The system of any of claims 15 to 29, in which the light source is a laser light source.
31. The system of claim 30, in which said laser light source is selected from a pulsed diode laser, a set of pulsed diode lasers, and a tunable laser source .
32. The system of claim 31, for use in measuring blood glucose concentration, in which the light source is a laser diode with a wavelength in the range of approximately 600 nm to 10,000 nm and a pulse duration of the order of 5 to 500 ns .
33 The system of any of claims 30 to 32, in which the light transmission means is arranged to produce a spot size of the order of 0.05 mm to 0.50 mm.
34. The system of any of claims 15 to 29, in which there are multiple light sources and means are provided for time multiplexing the multiple sources such that: each source is switched on and generates an optical pulse, or a set of optical pulses, the pulse, or set of pulses, generates an acoustic signal that is detected by the detector, and each source is pulsed in sequence until all sources have been used to generate their own signals.
35. The measuring system of any of claims 15 to 34, in the form of a self contained system including a power supply and a readout, which may be carried on the person and used at any convenient time.
36. The system of claim 35, including facilities for connection to a cellular telephone, two-way pager or other communication device for routine transmission of measurements taken to a central data collection point.
37. The system of any of claims 15 to 36, further including means for manipulating the body part under measurement and for performing additional measurement of the tissue to obtain other information about the state of the physiology of the issue.
38. The system of claim 37, in which said manipulating a. means includes means for squeezing a body part, such as an earlobe, and means for making photo acoustic measurements at several different pressures.
39. The system of claim 37 or claim 36, including temperature measurement means for measuring the temperature of the body site, and in which the signal processing means is arranged to apply a correction to the measurements based upon the temperature of the body site.
40. The system of claim 39, further including means for inducing temperatures above and below ambient in the body part.
41. The system of any of claims 15 to 40, comprising a means for storing one or both of calibration coefficients and operational parameters in order to calibrate the instrument and to set critical operational parameters.
42. The system of claim 41, in which the signal processing means is operable to adjust the calibration coefficients and operational parameters to be specific to a particular person.
43. The system of claim 42, when dependent upon claim 14, in which the calibration coefficients and operational parameters specific to a particular person are contained in a storage site located in the removable insert.
44. The system of claim 43, in which additionally calibration coefficients and operational parameters specific to the reader system are stored in the non-removable housing.
45. The measuring system of any of claims 15 to 44, further including connection means for connecting the measuring system to an invasive measuring system for the purpose of calibrating or adjusting the operational parameters of the non-invasive measuring system.
46. The system of claim 45, in which the connection means is selected from a cable link, IR link or radio waves .
47. A method of operating a measurement system as claimed in claim 34 to remove instrument drift from the measurement, the method comprising the steps of:
1) placing a calibration standard in the reader in place of the body part;
2) measuring the signal from the standard for each wavelength and storing the values in the calibration storage location;
3) before making a measurement of a body part, placing the calibration standard in the reader;
4) measuring the signal from the standard for each source;
5) comparing the just measured standard values to the stored calibration values;
6) calculating correction factors for each a. source wavelength.
7) removing the standard and placing the body part in the reader;
8) measuring the signal from the body part for each source; and
9) adjusting the measured values using the calculated correction factors.
48. The method of claim 47, in which a further correction factor is calculated for the instrument temperature.
49 A method of measuring a biological parameter in a subject, the method comprising the steps of:
directing one or more pulses of optical energy from the exterior into the tissue of a subject along a beam axis, the optical energy having a wavelength selected to be absorbed by tissue components of interest, thereby to produce a photoacoustic interaction;
detecting acoustic energy resulting from said photoacoustic reaction by means of a transducer positioned to intercept acoustic energy propagating in a direction other than the forward direction of said beam axis; and deriving from said detected acoustic energy a measure of the parameter of interest.
The method of claim 49, in which the parameter of interest is blood glucose, and the optical energy has a wavelength in the range of approximately 600 mm to 10,000 mm and a pulse duration of the order of 5 to 500 ms.
The method of claim 49 or claim 50, in which a train of pulses is applied and the detected signals are averaged to derive said measure.
The method of any of claims 49 to 51, in which said measure is derived from the energy of the detected signal.
The method of any of claims 49 to 52, in which the optical energy is directed into a body part which is substantially composed of soft tissue and free of bone.
Apparatus for measuring a biological parameter in a subject, the apparatus comprising:
means for directing one or more pulses of optical energy from the exterior into the tissue of a subject along a beam axis, the optical energy having a wavelength selected to be absorbed by tissue components of interest, thereby to produce a photoacoustic interaction;
transducer means arranged to detect acoustic energy resulting from said photoacoustic reaction by intercepting acoustic energy propagating in a direction other than the forward direction of said beam axis; and
means for deriving from said detected acoustic energy a measure of the parameter of interest.
Apparatus according to claim 54, in which said a. directing means incudes means for receiving a selected body part such that the optical energy is directed into a portion of the subject's body which is substantially free of bone.
A method of correcting measurement of an analyte based on a photoacoustic signal obtained from a living being comprising determining the concentration of other constituents in the being which have a significant effect on the photoacoustic signal and tend to vary from individual to individual or over time, and adjusting the measurement to remove the effect of variations in the concentrations of said other constituents.
The method of claim 56 in which the analyte is glucose.
The method of claim 57 in which the concentration of haemoglobin is determined and used to adjust the measurement.
A method of establishing a photoacoustic signal obtained from a living being comprising using the ratio of the acoustic signal obtained to the optical signal which generated the acoustic signal to determine the concentration of an analyte present in said being. The method of claim 59 in which the analyte is glucose.
A method of normalizing a photoacoustic signal obtained from directing an optical beam on the tissue of a living being comprising determining a. the dependence of the photoacoustic signal on the energy of the optical beam from a series of measurements at different energies for the type of tissue involved.
PCT/GB1998/000702 1997-03-07 1998-03-09 Biological measurement system WO1998038904A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002282855A CA2282855A1 (en) 1997-03-07 1998-03-09 Biological measurement system
JP53829398A JP2001526557A (en) 1997-03-07 1998-03-09 Biological measurement system
EP98909587A EP0967913A1 (en) 1997-03-07 1998-03-09 Biological measurement system
US09/380,640 US6403944B1 (en) 1997-03-07 1998-03-09 System for measuring a biological parameter by means of photoacoustic interaction
AU64079/98A AU6407998A (en) 1997-03-07 1998-03-09 Biological measurement system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9704737.7 1997-03-07
GBGB9704737.7A GB9704737D0 (en) 1997-03-07 1997-03-07 Biological measurement system

Publications (1)

Publication Number Publication Date
WO1998038904A1 true WO1998038904A1 (en) 1998-09-11

Family

ID=10808856

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1998/000702 WO1998038904A1 (en) 1997-03-07 1998-03-09 Biological measurement system

Country Status (7)

Country Link
US (2) US6403944B1 (en)
EP (1) EP0967913A1 (en)
JP (1) JP2001526557A (en)
AU (1) AU6407998A (en)
CA (1) CA2282855A1 (en)
GB (1) GB9704737D0 (en)
WO (1) WO1998038904A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015776A1 (en) 2000-08-24 2002-02-28 Glucon Inc. Photoacoustic assay and imaging system
US6405069B1 (en) 1996-01-31 2002-06-11 Board Of Regents, The University Of Texas System Time-resolved optoacoustic method and system for noninvasive monitoring of glucose
WO2002068937A1 (en) * 2001-02-27 2002-09-06 Institut für Bioprozess- und Analysenmesstechnik e.V. Device and method for measuring the concentration of at least one substance in a sample
WO2003039364A2 (en) * 2001-11-07 2003-05-15 University College London Blood flow velocity measurement
WO2004062491A1 (en) 2003-01-13 2004-07-29 Glucon Inc. Photoacoustic assay method and apparatus
WO2004107971A2 (en) 2003-06-09 2004-12-16 Glucon Inc. Wearable glucometer
US6921366B2 (en) 2002-03-20 2005-07-26 Samsung Electronics Co., Ltd. Apparatus and method for non-invasively measuring bio-fluid concentrations using photoacoustic spectroscopy
WO2006097933A2 (en) 2005-03-17 2006-09-21 Glucon Inc. Method for monitoring changes in blood glucose level
US7315767B2 (en) 2001-03-06 2008-01-01 Solianis Holding Ag Impedance spectroscopy based systems and methods
US7646484B2 (en) 2002-10-07 2010-01-12 Intellidx, Inc. Method and apparatus for performing optical measurements of a material
US8332006B2 (en) 2004-05-06 2012-12-11 Nippon Telegraph And Telephone Corporation Constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method
US8437821B2 (en) 2009-01-06 2013-05-07 Panasonic Corporation Non-invasive body information measurement apparatus
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9320466B2 (en) 2009-07-02 2016-04-26 Dexcom, Inc. Analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
CN108209940A (en) * 2016-12-14 2018-06-29 现代自动车株式会社 Optoacoustic, noninvasive and continuous blood glucose measuring device
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor

Families Citing this family (204)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
GB9915082D0 (en) * 1999-06-28 1999-08-25 Univ London Optical fibre probe
US6400971B1 (en) * 1999-10-12 2002-06-04 Orsense Ltd. Optical device for non-invasive measurement of blood-related signals and a finger holder therefor
US6534012B1 (en) * 2000-08-02 2003-03-18 Sensys Medical, Inc. Apparatus and method for reproducibly modifying localized absorption and scattering coefficients at a tissue measurement site during optical sampling
US8039261B2 (en) * 2000-11-17 2011-10-18 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
DE60238119D1 (en) 2001-06-12 2010-12-09 Pelikan Technologies Inc ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
EP1404232B1 (en) 2001-06-12 2009-12-02 Pelikan Technologies Inc. Blood sampling apparatus and method
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US20050085725A1 (en) * 2001-08-09 2005-04-21 Ron Nagar Photoacoustic assay and imaging system
US6668654B2 (en) 2001-08-15 2003-12-30 Lockheed Martin Corporation Method and apparatus for generating specific frequency response for ultrasound testing
US7064329B2 (en) * 2001-08-21 2006-06-20 Franalytica, Inc. Amplifier-enhanced optical analysis system and method
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7366564B2 (en) * 2002-08-23 2008-04-29 The United States Of America As Represented By The Secretary Of The Navy Nonlinear blind demixing of single pixel underlying radiation sources and digital spectrum local thermometer
US7727181B2 (en) 2002-10-09 2010-06-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
EP2386758A1 (en) 2002-10-09 2011-11-16 Abbott Diabetes Care Inc. A method of pumping a predetermined dose of a medical fluid
US7993108B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US7248912B2 (en) * 2002-10-31 2007-07-24 The Regents Of The University Of California Tissue implantable sensors for measurement of blood solutes
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7154592B2 (en) * 2003-02-11 2006-12-26 Bayer Healthcare Llc. Multiwavelength readhead for use in the determination of analytes in body fluids
GB0308324D0 (en) * 2003-04-10 2003-05-14 Piezoptic Ltd A chemical sensing device
US7679407B2 (en) 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
JP3566276B1 (en) 2003-05-07 2004-09-15 株式会社日立製作所 Blood glucose meter
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8071028B2 (en) 2003-06-12 2011-12-06 Abbott Diabetes Care Inc. Method and apparatus for providing power management in data communication systems
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US20080119703A1 (en) 2006-10-04 2008-05-22 Mark Brister Analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US20050044909A1 (en) * 2003-08-28 2005-03-03 Volker Lange Knob cylinder with biometrical sensor
US20050054906A1 (en) * 2003-09-08 2005-03-10 Joseph Page Spatial detectors for in-vivo measurement of bio chemistry
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8425417B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8425416B2 (en) 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005068973A1 (en) * 2004-01-13 2005-07-28 Glucon Inc. Photoacoustic sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
JP2006094992A (en) * 2004-09-29 2006-04-13 Hitachi Ltd Apparatus and method for measuring blood sugar
JP2006115947A (en) * 2004-10-19 2006-05-11 Hitachi Ltd Blood-sugar level measuring apparatus
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
CN101180093B (en) 2005-03-21 2012-07-18 雅培糖尿病护理公司 Method and system for providing integrated medication infusion and analyte monitoring system
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US7620437B2 (en) 2005-06-03 2009-11-17 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
JP4779522B2 (en) * 2005-09-13 2011-09-28 澁谷工業株式会社 Component inspection method and apparatus
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US20070088206A1 (en) * 2005-10-14 2007-04-19 Peyman Gholam A Photoacoustic measurement of analyte concentration in the eye
US8554296B2 (en) 2005-10-14 2013-10-08 Gholam A. Peyman Photoacoustic measurement of analyte concentration in the eye
US20070093698A1 (en) * 2005-10-20 2007-04-26 Glucon Inc. Apparatus and methods for attaching a device to a body
US20070093717A1 (en) * 2005-10-20 2007-04-26 Glucon Inc. Wearable glucometer configurations
US7583190B2 (en) 2005-10-31 2009-09-01 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
WO2007100937A2 (en) * 2006-01-19 2007-09-07 The Regents Of The University Of Michigan System and method for spectroscopic photoacoustic tomography
US8344966B2 (en) 2006-01-31 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing a fault tolerant display unit in an electronic device
US8145288B2 (en) 2006-08-22 2012-03-27 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US8449464B2 (en) 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US8478377B2 (en) 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
US8562528B2 (en) 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8275438B2 (en) 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
DE602006008156D1 (en) * 2006-10-31 2009-09-10 Johnson & Johnson Consumer Fr System and method for the acoustic determination of skin textures
US20080123083A1 (en) * 2006-11-29 2008-05-29 The Regents Of The University Of Michigan System and Method for Photoacoustic Guided Diffuse Optical Imaging
US20080173093A1 (en) * 2007-01-18 2008-07-24 The Regents Of The University Of Michigan System and method for photoacoustic tomography of joints
WO2008101019A2 (en) * 2007-02-13 2008-08-21 Board Of Regents, The University Of Texas System Molecular specific photoacoustic imaging
US20080221647A1 (en) * 2007-02-23 2008-09-11 The Regents Of The University Of Michigan System and method for monitoring photodynamic therapy
JP5031404B2 (en) * 2007-03-01 2012-09-19 新日本製鐵株式会社 Method for evaluating the state of the measurement object
US20080220512A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Tunable laser-based spectroscopy system for non-invasively measuring body water content
US20080228073A1 (en) * 2007-03-12 2008-09-18 Silverman Ronald H System and method for optoacoustic imaging of peripheral tissues
US20080306444A1 (en) 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
RU2010114587A (en) 2007-09-13 2011-10-20 Дзе Кьюрейторз Оф Дзе Юниверсити Оф Миссури (Us) OPTICAL DEVICE COMPONENTS
CN101903757B (en) 2007-10-04 2012-08-29 密苏里大学董事会 Optical device components
EP2227132B1 (en) 2007-10-09 2023-03-08 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8677829B2 (en) * 2007-10-16 2014-03-25 Koninklijke Philips N.V. Apparatus, systems and methods for production and integration of compact illumination schemes
US7961305B2 (en) * 2007-10-23 2011-06-14 The Curators Of The University Of Missouri Optical device components
JP5643101B2 (en) 2007-10-25 2014-12-17 ワシントン・ユニバーシティWashington University Scattering medium imaging method, imaging apparatus, and imaging system
WO2010048258A1 (en) * 2008-10-23 2010-04-29 Washington University In St. Louis Reflection-mode photoacoustic tomography using a flexibly-supported cantilever beam
US20090156932A1 (en) 2007-12-13 2009-06-18 Board Of Trustees Of The University Of Arkansas Device and method for in vivo flow cytometry using the detection of photoacoustic waves
US9451884B2 (en) 2007-12-13 2016-09-27 Board Of Trustees Of The University Of Arkansas Device and method for in vivo detection of clots within circulatory vessels
US9144383B2 (en) 2007-12-13 2015-09-29 The Board Of Trustees Of The University Of Arkansas Device and method for in vivo noninvasive magnetic manipulation of circulating objects in bioflows
US20090177051A1 (en) * 2008-01-09 2009-07-09 Heal-Ex, Llc Systems and methods for providing sub-dressing wound analysis and therapy
WO2009120600A2 (en) 2008-03-25 2009-10-01 The Curators Of The University Of Missouri Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
CN102961146B (en) 2008-05-22 2015-09-23 密苏里大学董事会 The method and system of noninvasive Optical blood glucose detection is carried out with spectral data analysis
US8886334B2 (en) 2008-10-07 2014-11-11 Mc10, Inc. Systems, methods, and devices using stretchable or flexible electronics for medical applications
WO2010042653A1 (en) 2008-10-07 2010-04-15 Mc10, Inc. Catheter balloon having stretchable integrated circuitry and sensor array
US8097926B2 (en) 2008-10-07 2012-01-17 Mc10, Inc. Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy
JP5241465B2 (en) * 2008-12-11 2013-07-17 キヤノン株式会社 Photoacoustic imaging apparatus and photoacoustic imaging method
US9351705B2 (en) 2009-01-09 2016-05-31 Washington University Miniaturized photoacoustic imaging apparatus including a rotatable reflector
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
JP2012522579A (en) * 2009-04-01 2012-09-27 ザ・キュレーターズ・オブ・ザ・ユニバーシティ・オブ・ミズーリ Methods of use associated with optical spectroscopy devices for non-invasive detection of blood glucose
US20100285518A1 (en) * 2009-04-20 2010-11-11 The Curators Of The University Of Missouri Photoacoustic detection of analytes in solid tissue and detection system
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
US20120197117A1 (en) * 2009-05-19 2012-08-02 Endra, Inc. Thermoacoustic system for analyzing tissue
JP2011004790A (en) * 2009-06-23 2011-01-13 Canon Inc Photoacoustic measurement apparatus
WO2011011739A2 (en) 2009-07-23 2011-01-27 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US9723122B2 (en) 2009-10-01 2017-08-01 Mc10, Inc. Protective cases with integrated electronics
JPWO2011052061A1 (en) 2009-10-29 2013-03-14 キヤノン株式会社 Photoacoustic device
JP5675142B2 (en) * 2010-03-29 2015-02-25 キヤノン株式会社 Subject information acquisition apparatus, subject information acquisition method, and program for executing subject information acquisition method
JP5709399B2 (en) * 2010-04-02 2015-04-30 キヤノン株式会社 SUBJECT INFORMATION ACQUISITION DEVICE, ITS CONTROL METHOD, AND PROGRAM
WO2011127428A2 (en) 2010-04-09 2011-10-13 Washington University Quantification of optical absorption coefficients using acoustic spectra in photoacoustic tomography
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
JP5553672B2 (en) 2010-04-26 2014-07-16 キヤノン株式会社 Acoustic wave measuring apparatus and acoustic wave measuring method
WO2011137385A1 (en) * 2010-04-30 2011-11-03 Visualsonics Inc. Photoacoustic transducer and imaging system
WO2011152747A1 (en) 2010-06-01 2011-12-08 H.L Human Laser Limited Photoacoustic material analysis
US8686335B2 (en) 2011-12-31 2014-04-01 Seno Medical Instruments, Inc. System and method for adjusting the light output of an optoacoustic imaging system
US9289191B2 (en) 2011-10-12 2016-03-22 Seno Medical Instruments, Inc. System and method for acquiring optoacoustic data and producing parametric maps thereof
US8997572B2 (en) 2011-02-11 2015-04-07 Washington University Multi-focus optical-resolution photoacoustic microscopy with ultrasonic array detection
EP2681538B1 (en) * 2011-03-11 2019-03-06 Mc10, Inc. Integrated devices to facilitate quantitative assays and diagnostics
DK3575796T3 (en) 2011-04-15 2021-01-18 Dexcom Inc ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION
EP2712491B1 (en) 2011-05-27 2019-12-04 Mc10, Inc. Flexible electronic structure
WO2013016573A1 (en) 2011-07-26 2013-01-31 Glysens Incorporated Tissue implantable sensor with hermetically sealed housing
US9055869B2 (en) 2011-10-28 2015-06-16 Covidien Lp Methods and systems for photoacoustic signal processing
US9445786B2 (en) * 2011-11-02 2016-09-20 Seno Medical Instruments, Inc. Interframe energy normalization in an optoacoustic imaging system
US8886294B2 (en) 2011-11-30 2014-11-11 Covidien Lp Methods and systems for photoacoustic monitoring using indicator dilution
US9186068B2 (en) 2011-12-05 2015-11-17 Covidien Lp Methods and systems for photoacoustic monitoring using hypertonic and isotonic indicator dilutions
US9131852B2 (en) 2011-12-05 2015-09-15 Covidien Lp Methods and systems for photoacoustic monitoring using indicator dilution
US20130190596A1 (en) * 2012-01-23 2013-07-25 Alexander A. Oraevsky Dynamic Optoacoustic Angiography of Peripheral Vasculature
US9851443B2 (en) * 2012-03-16 2017-12-26 Alcatel Lucent Optical beam sweeper
US8885155B2 (en) 2012-04-30 2014-11-11 Covidien Lp Combined light source photoacoustic system
US10561353B2 (en) 2016-06-01 2020-02-18 Glysens Incorporated Biocompatible implantable sensor apparatus and methods
US10660550B2 (en) 2015-12-29 2020-05-26 Glysens Incorporated Implantable sensor apparatus and methods
WO2014052449A1 (en) 2012-09-25 2014-04-03 The Board Of Trustees Of The University Of Arkansas Device and method for in vivo photoacoustic diagnosis and photothermal purging of infected blood
US9171794B2 (en) 2012-10-09 2015-10-27 Mc10, Inc. Embedding thin chips in polymer
US11020006B2 (en) 2012-10-18 2021-06-01 California Institute Of Technology Transcranial photoacoustic/thermoacoustic tomography brain imaging informed by adjunct image data
US9380981B2 (en) 2013-03-15 2016-07-05 Covidien Lp Photoacoustic monitoring technique with noise reduction
WO2014190330A1 (en) * 2013-05-24 2014-11-27 Fujifilm Sonosite, Inc. Photoacoustic transducer with optical feedback
US10308972B2 (en) * 2013-06-17 2019-06-04 Sanofi Chimie Whole-cell system for cytochrome P450 monooxygenases biocatalysis
US10168305B2 (en) 2013-10-17 2019-01-01 Battelle Memorial Institute Container screening system and method
US11137375B2 (en) 2013-11-19 2021-10-05 California Institute Of Technology Systems and methods of grueneisen-relaxation photoacoustic microscopy and photoacoustic wavefront shaping
US10724968B2 (en) 2014-03-21 2020-07-28 Battelle Memorial Institute System and method for solution constituent and concentration identification
US10234404B2 (en) 2014-03-21 2019-03-19 Battelle Memorial Institute Liquid scanning system and method for IV drug verification and identification
US10495567B2 (en) * 2014-05-14 2019-12-03 Canon Kabushiki Kaisha Photoacoustic apparatus
WO2016014393A1 (en) 2014-07-23 2016-01-28 Bayer Healthcare Llc Light switching indicators by wavelength filtration
CA2970536C (en) 2014-12-31 2023-09-26 Vladimir Pavlovich Zharov Devices and methods for fractionated photoacoustic flow cytometry
WO2016191307A1 (en) * 2015-05-22 2016-12-01 Cercacor Laboratories, Inc. Non-invasive optical physiological differential pathlength sensor
JP6100322B2 (en) * 2015-07-02 2017-03-22 キヤノン株式会社 Acoustic wave measuring apparatus and acoustic wave measuring method
US10638962B2 (en) 2016-06-29 2020-05-05 Glysens Incorporated Bio-adaptable implantable sensor apparatus and methods
EP3329847A1 (en) * 2016-11-30 2018-06-06 Inreda Diabetic B.V. Apparatus for regulating the concentration of glucose in the blood of a person
WO2018209046A1 (en) 2017-05-10 2018-11-15 Washington University Snapshot photoacoustic photography using an ergodic relay
US10638979B2 (en) 2017-07-10 2020-05-05 Glysens Incorporated Analyte sensor data evaluation and error reduction apparatus and methods
AU2018354120A1 (en) 2017-10-24 2020-04-23 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11278668B2 (en) 2017-12-22 2022-03-22 Glysens Incorporated Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods
US11255839B2 (en) 2018-01-04 2022-02-22 Glysens Incorporated Apparatus and methods for analyte sensor mismatch correction
JP6845182B2 (en) * 2018-05-01 2021-03-17 日本電信電話株式会社 Component concentration measuring device
WO2020037082A1 (en) 2018-08-14 2020-02-20 California Institute Of Technology Multifocal photoacoustic microscopy through an ergodic relay
WO2020051246A1 (en) 2018-09-04 2020-03-12 California Institute Of Technology Enhanced-resolution infrared photoacoustic microscopy and spectroscopy
US11369280B2 (en) 2019-03-01 2022-06-28 California Institute Of Technology Velocity-matched ultrasonic tagging in photoacoustic flowgraphy
US10746716B1 (en) 2019-05-31 2020-08-18 Battelle Memorial Institute System and method for solution constituent and concentration identification
CN113243911B (en) * 2020-02-13 2023-10-20 深圳绿米联创科技有限公司 Detection method, device, apparatus, electronic equipment and storage medium
JP2023550234A (en) * 2020-09-29 2023-12-01 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Use of optical energy meters in normalizing acoustic signals produced by laser pulses of various wavelengths to enable accurate calculations of blood oxygenation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0413330A2 (en) * 1989-08-16 1991-02-20 Hitachi, Ltd. Method and apparatus for detecting photoacoustic signal
JPH06317566A (en) * 1993-05-06 1994-11-15 Hitachi Ltd Method and apparatus for optoacoustic analysis as well as blood component measuring apparatus utilizing them
JPH07136150A (en) * 1993-11-16 1995-05-30 Nippon Koden Corp Optoacoustic pulse oxymeter
DE4400674A1 (en) * 1994-01-12 1995-07-27 Siemens Ag Photo-acoustic sensor for diagnostic laser absorption spectrometer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO880891L (en) 1987-03-03 1988-09-05 Elizabeth May Dowling PROCEDURE AND APPARATUS FOR MEASURING OR DETECTING THE CONCENTRATION OF A SUBSTANCE.
JPH01191040A (en) 1988-01-27 1989-08-01 Shiseido Co Ltd Optoacoustic measuring instrument
US5074309A (en) * 1989-12-04 1991-12-24 Sperry Marine Inc. Device for monitoring cardiovascular signals and fiber optic coupler phonocardio sensor therefor
JPH04357440A (en) * 1990-08-20 1992-12-10 Shiseido Co Ltd Photoacoustic cell and photoacoustic measuring apparatus
US5348002A (en) 1992-04-23 1994-09-20 Sirraya, Inc. Method and apparatus for material analysis
US5348003A (en) 1992-09-03 1994-09-20 Sirraya, Inc. Method and apparatus for chemical analysis
US5579001A (en) * 1994-10-20 1996-11-26 Hewlett-Packard Co. Paging-based backchannel in a medical telemetry system
FR2728452B1 (en) 1994-12-22 1997-07-25 Dior Christian Parfums DEVICE FOR PHOTOACOUSTIC ANALYSIS OF SKIN IN SITU
SE9600322L (en) * 1996-01-30 1997-07-31 Hoek Instr Ab Sensor for pulse oximetry with fiber optic signal transmission
US5840023A (en) * 1996-01-31 1998-11-24 Oraevsky; Alexander A. Optoacoustic imaging for medical diagnosis
US5702284A (en) 1996-03-19 1997-12-30 Gallegos; Carlos R. Party wheel
DE19632864C2 (en) 1996-08-14 2000-08-10 Columbus Schleif Und Zerspante Differential measuring head for photoacoustic spectroscopy
WO1998052466A1 (en) * 1997-05-21 1998-11-26 Lucent Medical Systems, Inc. Non-invasive sensing of a physical parameter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0413330A2 (en) * 1989-08-16 1991-02-20 Hitachi, Ltd. Method and apparatus for detecting photoacoustic signal
JPH06317566A (en) * 1993-05-06 1994-11-15 Hitachi Ltd Method and apparatus for optoacoustic analysis as well as blood component measuring apparatus utilizing them
JPH07136150A (en) * 1993-11-16 1995-05-30 Nippon Koden Corp Optoacoustic pulse oxymeter
DE4400674A1 (en) * 1994-01-12 1995-07-27 Siemens Ag Photo-acoustic sensor for diagnostic laser absorption spectrometer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A. MANDELIS: "frequency modulated (FM) time delay photoacoustic and photothermal wave spectroscopies. Technique, instrumentation, and detection. Part I: Theoretical", REVIEW OF SCIENTIFIC INSTRUMENTS, vol. 57, no. 4, - April 1986 (1986-04-01), WOODBURY, US, pages 617 - 621, XP002065818 *
CHRISTISON G B ET AL: "LASER PHOTOACOUSTIC DETERMINATION OF PHYSIOLOGICAL GLUCOSE CONCENTRATIONS IN HUMAN WHOLE BLOOD", MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING, vol. 31, no. 3, 1 May 1993 (1993-05-01), STEVENAGE,GB, pages 284 - 290, XP000367215 *
G.SPANNER ET AL: "Noninvasive determination of blood constituents using an array of modulated laser diodes and a photoacoustic sensor head", FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, vol. 355, no. 3/4, June 1996 (1996-06-01), SPRINGER-VERLAG , DE, pages 327 - 328, XP002066087 *
PATENT ABSTRACTS OF JAPAN vol. 095, no. 002 31 March 1995 (1995-03-31) *
PATENT ABSTRACTS OF JAPAN vol. 095, no. 008 29 September 1995 (1995-09-29) *

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6405069B1 (en) 1996-01-31 2002-06-11 Board Of Regents, The University Of Texas System Time-resolved optoacoustic method and system for noninvasive monitoring of glucose
EP1700563A2 (en) 2000-08-24 2006-09-13 Glucon Inc. Photoacoustic assay and imaging system
WO2002015776A1 (en) 2000-08-24 2002-02-28 Glucon Inc. Photoacoustic assay and imaging system
US6846288B2 (en) 2000-08-24 2005-01-25 Glucon Inc. Photoacoustic assay and imaging system
WO2002068937A1 (en) * 2001-02-27 2002-09-06 Institut für Bioprozess- und Analysenmesstechnik e.V. Device and method for measuring the concentration of at least one substance in a sample
US7315767B2 (en) 2001-03-06 2008-01-01 Solianis Holding Ag Impedance spectroscopy based systems and methods
WO2003039364A2 (en) * 2001-11-07 2003-05-15 University College London Blood flow velocity measurement
WO2003039364A3 (en) * 2001-11-07 2003-10-16 Univ London Blood flow velocity measurement
US6921366B2 (en) 2002-03-20 2005-07-26 Samsung Electronics Co., Ltd. Apparatus and method for non-invasively measuring bio-fluid concentrations using photoacoustic spectroscopy
US7646484B2 (en) 2002-10-07 2010-01-12 Intellidx, Inc. Method and apparatus for performing optical measurements of a material
WO2004062491A1 (en) 2003-01-13 2004-07-29 Glucon Inc. Photoacoustic assay method and apparatus
WO2004107971A2 (en) 2003-06-09 2004-12-16 Glucon Inc. Wearable glucometer
US9060691B2 (en) 2004-05-06 2015-06-23 Nippon Telegraph And Telephone Corporation Constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method
US8332006B2 (en) 2004-05-06 2012-12-11 Nippon Telegraph And Telephone Corporation Constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method
US9198580B2 (en) 2004-05-06 2015-12-01 Nippon Telegraph And Telephone Corporation Constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method
US9008742B2 (en) 2004-05-06 2015-04-14 Nippon Telegraph And Telephone Corporation Constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method
US11026605B1 (en) 2004-07-13 2021-06-08 Dexcom, Inc. Analyte sensor
US10918314B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10799159B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US11064917B2 (en) 2004-07-13 2021-07-20 Dexcom, Inc. Analyte sensor
US10993641B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US10993642B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US10980452B2 (en) 2004-07-13 2021-04-20 Dexcom, Inc. Analyte sensor
US10932700B2 (en) 2004-07-13 2021-03-02 Dexcom, Inc. Analyte sensor
US10524703B2 (en) 2004-07-13 2020-01-07 Dexcom, Inc. Transcutaneous analyte sensor
US11045120B2 (en) 2004-07-13 2021-06-29 Dexcom, Inc. Analyte sensor
US10918313B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918315B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10827956B2 (en) 2004-07-13 2020-11-10 Dexcom, Inc. Analyte sensor
US10709363B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10709362B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10813576B2 (en) 2004-07-13 2020-10-27 Dexcom, Inc. Analyte sensor
US10722152B2 (en) 2004-07-13 2020-07-28 Dexcom, Inc. Analyte sensor
US10799158B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
WO2006097933A2 (en) 2005-03-17 2006-09-21 Glucon Inc. Method for monitoring changes in blood glucose level
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US11102306B2 (en) 2008-02-21 2021-08-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8437821B2 (en) 2009-01-06 2013-05-07 Panasonic Corporation Non-invasive body information measurement apparatus
US9907497B2 (en) 2009-07-02 2018-03-06 Dexcom, Inc. Analyte sensor
US9320466B2 (en) 2009-07-02 2016-04-26 Dexcom, Inc. Analyte sensor
US10420494B2 (en) 2009-07-02 2019-09-24 Dexcom, Inc. Analyte sensor
US11559229B2 (en) 2009-07-02 2023-01-24 Dexcom, Inc. Analyte sensor
CN108209940A (en) * 2016-12-14 2018-06-29 现代自动车株式会社 Optoacoustic, noninvasive and continuous blood glucose measuring device

Also Published As

Publication number Publication date
AU6407998A (en) 1998-09-22
US20030010898A1 (en) 2003-01-16
US6403944B1 (en) 2002-06-11
GB9704737D0 (en) 1997-04-23
CA2282855A1 (en) 1998-09-11
US6833540B2 (en) 2004-12-21
EP0967913A1 (en) 2000-01-05
JP2001526557A (en) 2001-12-18

Similar Documents

Publication Publication Date Title
US6403944B1 (en) System for measuring a biological parameter by means of photoacoustic interaction
GB2322941A (en) In-vivo photoacoustic measurement
CA2704789C (en) Optical sensor for determining the concentration of an analyte
US6026314A (en) Method and device for noninvasive measurements of concentrations of blood components
US5370114A (en) Non-invasive blood chemistry measurement by stimulated infrared relaxation emission
JP3210632B2 (en) Apparatus for non-invasive measurement of blood glucose by photoacoustic
US5115133A (en) Testing of body fluid constituents through measuring light reflected from tympanic membrane
AU749033B2 (en) Apparatus and method for noninvasive glucose measurement
JP2001503999A (en) Measurement of tissue analytes by infrared
JP3994588B2 (en) Noninvasive blood glucose meter
CN107427219A (en) Optoacoustic sensing device further and its operating method
JP6444857B2 (en) Non-invasive measurement of analyte concentration using a fiberless transmission and reflection probe
KR100300960B1 (en) Method and device for noninvasive determination of the concentrations of blood components
CN209899401U (en) Four-wavelength combined noninvasive glucometer
US20230293055A1 (en) Smart-Tooth Blood Glucose Measurement Device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998909587

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2282855

Country of ref document: CA

Ref country code: CA

Ref document number: 2282855

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 538293

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998909587

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09380640

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1998909587

Country of ref document: EP